Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

47
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
47
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

105
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
105
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

705
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
705

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comparative Study of Plasticized Polyvinyl Alcohol and Hydroxypropyl Methylcellulose Films for Pharmaceutical Applications: Mechanical, Thermal, Structural and Disintegration Properties.

Polymers·2026
Same author

Beeswax in Pharmaceutical Sciences: A Comprehensive Review of Its Chemical Composition, Functional Applications, Types, and Formulation Roles.

International journal of molecular sciences·2026
Same author

Metabolic reprogramming in head and neck cancer: therapeutic opportunities and challenges.

The Journal of pharmacy and pharmacology·2026
Same author

mRNA-Based Therapeutics: Advances in Drug Delivery, Comparative Innovations, and Biomedical Applications.

Molecular pharmaceutics·2026
Same author

The role of PEDF in ageing and development: reduction of oxidative damage and support for stem cells.

The Journal of pharmacy and pharmacology·2025
Same author

Violacein: a natural antibacterial agent empowered by film-forming sprays for topical applications.

BMC complementary medicine and therapies·2025

Related Experiment Video

Updated: Sep 21, 2025

Preparation and Characterization of SDF-1α-Chitosan-Dextran Sulfate Nanoparticles
12:00

Preparation and Characterization of SDF-1α-Chitosan-Dextran Sulfate Nanoparticles

Published on: January 22, 2015

12.5K

Chitosan Nanoparticles in Atherosclerosis-Development to Preclinical Testing.

Pornsak Sriamornsak1,2,3, Crispin R Dass4,5

  • 1Department of Pharmaceutical Technology, Faculty of Pharmacy, Silpakorn University, Nakhon Pathom 73000, Thailand.

Pharmaceutics
|May 28, 2022
PubMed
Summary

Chitosan nanoparticles show promise for cardiovascular research, particularly in atherosclerosis treatment. Further investigation is needed to explore their diagnostic and therapeutic potential for clinical applications.

Keywords:
atherosclerosiscardiovascularchitosandrugnanoparticle

More Related Videos

Quantitative Analysis of Cellular Composition in Advanced Atherosclerotic Lesions of Smooth Muscle Cell Lineage-Tracing Mice
09:06

Quantitative Analysis of Cellular Composition in Advanced Atherosclerotic Lesions of Smooth Muscle Cell Lineage-Tracing Mice

Published on: February 20, 2019

8.4K
Microwave-driven Synthesis of Iron Oxide Nanoparticles for Fast Detection of Atherosclerosis
08:13

Microwave-driven Synthesis of Iron Oxide Nanoparticles for Fast Detection of Atherosclerosis

Published on: March 22, 2016

10.7K

Related Experiment Videos

Last Updated: Sep 21, 2025

Preparation and Characterization of SDF-1α-Chitosan-Dextran Sulfate Nanoparticles
12:00

Preparation and Characterization of SDF-1α-Chitosan-Dextran Sulfate Nanoparticles

Published on: January 22, 2015

12.5K
Quantitative Analysis of Cellular Composition in Advanced Atherosclerotic Lesions of Smooth Muscle Cell Lineage-Tracing Mice
09:06

Quantitative Analysis of Cellular Composition in Advanced Atherosclerotic Lesions of Smooth Muscle Cell Lineage-Tracing Mice

Published on: February 20, 2019

8.4K
Microwave-driven Synthesis of Iron Oxide Nanoparticles for Fast Detection of Atherosclerosis
08:13

Microwave-driven Synthesis of Iron Oxide Nanoparticles for Fast Detection of Atherosclerosis

Published on: March 22, 2016

10.7K

Area of Science:

  • Biomaterials Science
  • Cardiovascular Research
  • Nanotechnology

Background:

  • Chitosan is a natural, abundant, and safe biopolymer with cholesterol-reducing properties.
  • Chitosan nanoparticles are widely researched for cancer and diabetes but underutilized in cardiovascular research, specifically atherosclerosis.
  • There is a significant knowledge gap regarding chitosan's application in cardiovascular disease research.

Purpose of the Study:

  • To review the current research on chitosan nanoparticles in cardiovascular research, focusing on atherosclerosis.
  • To identify deficiencies and limitations in the existing body of research.
  • To propose future research directions and potential clinical applications.

Main Methods:

  • Literature review of studies utilizing chitosan nanoparticles for diagnostic and therapeutic purposes in cardiovascular research.
  • Analysis of research gaps and limitations in the application of chitosan nanoparticles for atherosclerosis.
  • Synthesis of findings to propose future research strategies.

Main Results:

  • Limited research exists on chitosan nanoparticles for atherosclerosis compared to other diseases.
  • Existing studies show potential for both diagnostic and therapeutic applications.
  • Deficiencies in research methodology and scope hinder clinical translation.

Conclusions:

  • Chitosan nanoparticles hold significant potential for advancing atherosclerosis diagnosis and therapy.
  • Further research is crucial to address current limitations and optimize nanoparticle design and application.
  • Future studies should focus on standardized methodologies and clinical trial preparedness.